IP Group PLC (IPO.L)

IPO.L on London Stock Exchange

2:53pm IST
Change (% chg)

5.70p (+2.52%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for IPO.L


IP Group Plc is a United Kingdom-based holding company. The Company operates in three segments: the commercialization of intellectual property through the formation of long-term partnerships with universities; management of venture funds focusing on early-stage United Kingdom technology companies, and the in-licensing of... (more)


Beta: 1.11
Market Cap(Mil.): £1,212.29
Shares Outstanding(Mil.): 536.41
Dividend: --
Yield (%): --


Search Stocks

BRIEF-IP Group says U.S. FDA grants portfolio co's Chronocort orphan drug designation

* Portfolio company Diurnal Limited granted orphan drug designation in U.S. Source text for Eikon: Further company coverage:

25 Mar 2015

BRIEF-IP Group to raise about 128 mln stg via firm placing

* Announces a share issue to raise gross proceeds of approximately gbp 128.0 million (approximately gbp 124.7 million net of expenses) through issue of 56,888,888 capital raising shares by way of a firm placing

10 Mar 2015

BRIEF-IP Group FY net assets 526.2 mln stg vs 337 mln stg

* FY adjusted profit before tax of £16.2m (2013: £77.6m), excluding items

10 Mar 2015

BRIEF-IP Group portfolio company Tissue Regenix raises 20 mln stg

* IP Group - portfolio company tissue regenix announces 20 million pounds funding round

22 Jan 2015

BRIEF-IP Group's Genomics raises 10.3 mln stg

* Funding came from new investors, including funds managed by Invesco Perpetual, Lansdowne Partners, Woodford Investment Management and Wylie Family Trust

26 Nov 2014

BRIEF-Fair value of IP Group's portfolio rises to 342.5 mln stg as at Nov 11

* As at Nov 11, 2014, fair value of group's portfolio was 342.5 million pounds compared to 319.6 mln stg at June 30, 2014 Source text for Eikon: Further company coverage:

13 Nov 2014

Earnings vs. Estimates

Search Stocks